A Single Arm Prospective Trial of Combining CyberKnife Fractionated Radiosurgery and PD-1 Inhibitor Nivolumab in the Treatment of Limited Number (=4) of Symptomatic Non-small-cell Lung Cancer Brain Metastases without Driver Mutations
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Nivolumab (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Dec 2020 New trial record